Melatonin: Roles and Molecular Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease
Biomolecules · 2026
DOI: 10.3390/biom16091357 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Binjing Pan und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Melatonin, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Science and Technology Innovation Projects in the Health Sector of Gansu Province, the joint Fund project of Gansu Province.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common metabolic disorder that affects the endocrine and digestive systems. It often leads to multi-system metabolic abnormalities, including disturbances in blood glucose and lipid levels. MASLD ranges from normal liver to steatosis, followed by fibrosis and cirrhosis, eventually leading to hepatocellular carcinoma. This disease can exacerbate liver-related complications and promote the development of extrahepatic diseases in other systems, including the cardiovascular and renal systems. Melatonin, a regulator of neurotransmitters, hormones, and biological responses, modulates oxidative stress, buffers free radicals, influences mitochondrial function, and regulates energy. Therefore, melatonin may serve as a novel adjunctive therapeutic agent for delaying or inhibiting the development of MASLD. We summarize the recent research progress on the effects of melatonin on MASLD and related molecular mechanisms, and identify new ideas and targets for MASLD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.
- Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
Förderung
- National Natural Science Foundation of China
- Major Science and Technology Innovation Projects in the Health Sector of Gansu Province
- the joint Fund project of Gansu Province
- joint Fund project of Gansu Province
Zitieren
APA
Pan, B., Lv, X., Guo, X., & Liu, J. (2026). Melatonin: Roles and Molecular Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomolecules. https://doi.org/10.3390/biom16091357
Vancouver
Pan B, Lv X, Guo X, Liu J. Melatonin: Roles and Molecular Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomolecules. 2026. doi:10.3390/biom16091357
BibTeX
@article{Pan2026,
author = {Pan, Binjing and Lv, Xiaoyu and Guo, Xinyuan and Liu, Jingfang},
title = {Melatonin: Roles and Molecular Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091357}
}
EUVIMED